MedPath

BRISTOL MYERS SQUIBB

🇺🇸United States
Ownership
-
Established
1989-01-01
Employees
30K
Market Cap
$97.5B
Website
https://www.bms.com/

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

Phase 3
Recruiting
Conditions
Sjögren's Syndrome
Interventions
Other: Placebo
First Posted Date
2023-07-14
Last Posted Date
2025-05-06
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
756
Registration Number
NCT05946941
Locations
🇮🇹

Local Institution - 0062, Rome, Italy

🇮🇹

Santa Maria della Misericordia, Udine, Italy

🇺🇸

Local Institution - 0225, The Woodlands, Texas, United States

and more 226 locations

Mavacamten Pregnancy Surveillance Program

Recruiting
Conditions
Breastfeeding
Hypertrophic Cardiomyopathy
Pregnancy Related
Interventions
First Posted Date
2023-07-11
Last Posted Date
2023-11-28
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
20
Registration Number
NCT05939700
Locations
🇺🇸

The Mavacamten Pregnancy Surveillance Program, PPD Inc, Wilmington, North Carolina, United States

A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants

Phase 1
Completed
Conditions
Healthy Participants
Interventions
First Posted Date
2023-07-06
Last Posted Date
2023-10-30
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
47
Registration Number
NCT05932303
Locations
🇨🇦

Local Institution - 0001, Québec, CA, Canada

A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants

First Posted Date
2023-07-06
Last Posted Date
2023-10-30
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
22
Registration Number
NCT05932277
Locations
🇺🇸

ICON Lenexa, Lenexa, Kansas, United States

Expanded Access for Repotrectinib

First Posted Date
2023-07-03
Last Posted Date
2023-07-03
Lead Sponsor
Bristol-Myers Squibb
Registration Number
NCT05926232

A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of Midazolam

Phase 1
Completed
Conditions
Healthy Participants
Interventions
First Posted Date
2023-06-13
Last Posted Date
2024-08-07
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
65
Registration Number
NCT05901714
Locations
🇺🇸

Local Institution - 0001, Miami, Florida, United States

A Study to Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effect Of Food on the Drug Levels of Iberdomide in Healthy Adult Participants

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
First Posted Date
2023-06-12
Last Posted Date
2024-07-26
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
32
Registration Number
NCT05899738
Locations
🇺🇸

Local Institution - 0001, Daytona Beach, Florida, United States

A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Participants

Phase 1
Completed
Conditions
Healthy Female Volunteers
Interventions
Drug: Loestrin
First Posted Date
2023-06-06
Last Posted Date
2023-09-25
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
15
Registration Number
NCT05891262
Locations
🇺🇸

Altasciences, Cypress, California, United States

A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

Phase 4
Active, not recruiting
Conditions
Anemia
Interventions
First Posted Date
2023-06-06
Last Posted Date
2025-04-16
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
60
Registration Number
NCT05891249
Locations
🇮🇳

Local Institution - 0001, New Delhi, Delhi, India

🇮🇳

Local Institution - 0002, Ahmedabad, Gujarat, India

🇮🇳

Local Institution - 0007, Kolkata, West Bengal, India

and more 6 locations

A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors

Phase 1
Recruiting
Conditions
Advanced Solid Tumors
Interventions
First Posted Date
2023-06-05
Last Posted Date
2025-05-09
Lead Sponsor
Bristol-Myers Squibb
Target Recruit Count
100
Registration Number
NCT05888831
Locations
🇫🇷

Institut Bergonie Centre Regional de Lutte Contre Le Cancer de Bordeaux Et Sud Ouest, Bordeaux, France

🇮🇹

Local Institution - 0023, Rozzano, Milano, Italy

🇮🇹

Local Institution - 0024, Siena, Toscana, Italy

and more 19 locations
© Copyright 2025. All Rights Reserved by MedPath